Jeffrey Zekauskas

Stock Analyst at JP Morgan

(3.91)
# 609
Out of 5,147 analysts
563
Total ratings
59.11%
Success rate
7%
Average return

Stocks Rated by Jeffrey Zekauskas

The Chemours Company
Feb 23, 2026
Maintains: Neutral
Price Target: $13$17
Current: $18.24
Upside: -6.80%
Nutrien
Feb 20, 2026
Maintains: Overweight
Price Target: $68$78
Current: $75.07
Upside: +3.90%
CF Industries Holdings
Feb 20, 2026
Maintains: Neutral
Price Target: $80$94
Current: $99.54
Upside: -5.57%
Celanese
Feb 19, 2026
Maintains: Neutral
Price Target: $40$53
Current: $49.94
Upside: +6.13%
Huntsman
Feb 19, 2026
Downgrades: Neutral
Price Target: $11$14
Current: $12.65
Upside: +10.67%
Valvoline
Feb 12, 2026
Downgrades: Underweight
Price Target: $30$35
Current: $37.80
Upside: -7.41%
Ecolab
Feb 11, 2026
Maintains: Neutral
Price Target: $265$295
Current: $308.35
Upside: -4.33%
Silgan Holdings
Feb 9, 2026
Maintains: Overweight
Price Target: $44$53
Current: $48.05
Upside: +10.30%
Avery Dennison
Feb 9, 2026
Maintains: Overweight
Price Target: $195$205
Current: $196.35
Upside: +4.41%
Linde
Feb 6, 2026
Downgrades: Neutral
Price Target: $455
Current: $508.08
Upside: -10.45%
Downgrades: Neutral
Price Target: $112$115
Current: $114.60
Upside: +0.35%
Downgrades: Neutral
Price Target: $75$77
Current: $80.12
Upside: -3.89%
Maintains: Overweight
Price Target: $77$70
Current: $62.36
Upside: +12.25%
Maintains: Neutral
Price Target: $50$60
Current: $67.13
Upside: -10.62%
Maintains: Neutral
Price Target: $260$280
Current: $275.67
Upside: +1.57%
Maintains: Neutral
Price Target: $23$26
Current: $30.73
Upside: -15.39%
Maintains: Overweight
Price Target: $117$126
Current: $123.27
Upside: +2.21%
Maintains: Neutral
Price Target: $80$195
Current: $178.67
Upside: +9.14%
Upgrades: Overweight
Price Target: $117$115
Current: $114.12
Upside: +0.77%
Maintains: Underweight
Price Target: $9$5
Current: $5.69
Upside: -12.13%
Maintains: Underweight
Price Target: $75$54
Current: $76.14
Upside: -29.08%
Maintains: Neutral
Price Target: $43$14
Current: $14.74
Upside: -5.02%
Maintains: Overweight
Price Target: $36$38
Current: $41.88
Upside: -9.26%
Maintains: Neutral
Price Target: $52$50
Current: $57.52
Upside: -13.07%
Upgrades: Overweight
Price Target: $33$38
Current: $50.53
Upside: -24.80%
Maintains: Neutral
Price Target: $30$29
Current: $33.41
Upside: -13.20%
Maintains: Overweight
Price Target: $378$385
Current: $362.59
Upside: +6.18%
Downgrades: Neutral
Price Target: n/a
Current: $7.48
Upside: -
Maintains: Neutral
Price Target: $73$78
Current: $105.38
Upside: -25.98%
Assumes: Overweight
Price Target: $56$50
Current: $48.43
Upside: +3.24%
Downgrades: Underweight
Price Target: $15$18
Current: $25.20
Upside: -28.57%
Maintains: Underweight
Price Target: $50$54
Current: $65.72
Upside: -17.83%
Maintains: Neutral
Price Target: $28$20
Current: $25.37
Upside: -21.17%
Maintains: Overweight
Price Target: $80$65
Current: $70.12
Upside: -7.30%
Maintains: Overweight
Price Target: $107$104
Current: $82.23
Upside: +26.47%
Maintains: Overweight
Price Target: $26$29
Current: $9.05
Upside: +220.44%
Maintains: Overweight
Price Target: $75$73
Current: $27.84
Upside: +162.21%
Upgrades: Overweight
Price Target: $80$75
Current: $70.62
Upside: +6.20%
Maintains: Overweight
Price Target: $68$70
Current: $75.51
Upside: -7.30%
Maintains: Overweight
Price Target: $92$110
Current: $170.02
Upside: -35.30%